Latest News about NVO
Recent news which mentions NVO
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
November 29, 2024
From Benzinga
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now
November 27, 2024
From Motley Fool
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
November 25, 2024
From Motley Fool
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
November 18, 2024
From Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
November 18, 2024
From Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
November 16, 2024
From Motley Fool
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
November 13, 2024
From Benzinga
What's Going On With Hims & Hers Health Stock On Wednesday?
November 13, 2024
From Benzinga
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
November 13, 2024
From Benzinga
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
November 12, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
From Benzinga
Decoding Novo Nordisk's Options Activity: What's the Big Picture?
November 11, 2024
Tickers
NVO
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
November 11, 2024
From Benzinga
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
November 10, 2024
From Motley Fool
Is Viking Therapeutics a Buy on the Dip?
November 10, 2024
From Motley Fool
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
Investors Like Certainty. Trump's Win Gave Them Some.
November 08, 2024
From Motley Fool
Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
November 07, 2024
From Benzinga
Forecasting The Future: 7 Analyst Projections For Novo Nordisk
November 06, 2024
Tickers
NVO
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.